Loading company…
London-based pharmacovigilance software company whose Reportum platform manages adverse event reporting.
MyMeds&Me provides adverse event management software, led by its Reportum platform, for capturing and analyzing adverse event data, drug safety concerns and product complaints. Headquartered in London, UK, with Andrew Rut as CEO, it sells subscriptions to healthcare organizations and pharmaceutical companies. Clario's Drug Safety and Pharmacovigilance Services Solutions division acquired it from Albion Capital in April 2022, and it is now part of Qinecsa Solutions. It is listed at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in